Education
About Us
Working with TipRanks
Follow Us
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
Abeona Therapeutics (ABEO) Ownership Overview
7.46% Insiders
5.57% Mutual Funds
50.61% Other Institutional Investors
5.55% ETFs
30.81% Public Companies and Individual Investors
The ownership structure of Abeona Therapeutics (ABEO) stock is a mix of institutional, retail, and individual investors. Approximately 61.73% of the company’s stock is owned by Institutional Investors, 7.46% is owned by Insiders, and 30.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 31, 2025 | Mark Alvino Director | xxxxxxxxxxxxx | $21520 |
| Jan 21, 2025 | Mark Alvino Director | xxxxxxxxxxxxx | $20400 |
| Jun 20, 2024 | Mark Alvino Director | xxxxxxxxxxxxx | $116764 |
| Jun 20, 2024 | Christine Berni Silverstein Director | xxxxxxxxxxxxx | $116453 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $11610208 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,935,527 | Institution | 4.45% | 11,651,873 | |
| 1,910,563 | Institution | 4.40% | 11,501,589 | |
| 1,698,097 | Institution | 3.91% | 10,222,544 | |
| 1,380,322 | Insider | 3.18% | 8,309,538 | |
| 509,726 | Insider | 1.17% | 3,068,551 | |
| 408,584 | Institution | 0.94% | 2,459,676 | |
| 402,123 | Institution | 0.93% | 2,420,780 | |
| 388,896 | Insider | 0.89% | 2,341,154 | |
| 180,466 | Insider | 0.42% | 1,086,405 | |
| 154,366 | Insider | 0.36% | 929,283 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,935,527 | Institution | 4.45% | 11,651,873 | |
| 402,123 | Institution | 0.93% | 2,420,780 | |
| 30,505 | Institution | 0.07% | 183,640 | |
| 23,850 | Institution | 0.05% | 143,577 | |
| 23,500 | Institution | 0.05% | 141,470 | |
| 6,798 | Institution | 0.02% | 40,924 | |
| 374 | Institution | <0.01% | 2,251 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,232,465 | Institution | 2.84% | 6,864,830 | |
| 678,098 | Institution | 1.56% | 3,777,006 | |
| 408,584 | Institution | 0.94% | 2,422,903 | |
| 89,068 | Institution | 0.20% | 536,189 | |
| 3,443 | Institution | <0.01% | 20,417 |
FAQ
Who Owns Abeona Therapeutics (ABEO)?
According to the latest TipRanks data, approximately 50.61% of the company's stock is held by institutional investors, 7.46% is held by insiders, and 30.81% is held by retail investors.
What percentage of Abeona Therapeutics (ABEO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 50.61% of Abeona Therapeutics (ABEO) stock is held by institutional investors.
What percentage of Abeona Therapeutics (ABEO) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.81% of Abeona Therapeutics (ABEO) stock is held by retail investors.
Who owns the most shares of Abeona Therapeutics (ABEO)?
VANGUARD INDEX FUNDS owns the most shares of Abeona Therapeutics (ABEO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.